Iron Chelation Drug Market

In a healthy body, when the stores of iron are sufficient, the intestines reduce the absorption of this mineral from food and drink to prevent its levels from rising too high.
People with iron overload disorders absorb more iron than usual from food or supplements. The body cannot excrete the extra iron fast enough, so it continues to build up. The body stores it in organ tissue, mainly in the liver, as well as the heart and the pancreas.
There are several types of iron overload disorder. Hereditary hemochromatosis is a primary condition that has a genetic component. People can also have secondary hemochromatosis, which develops as a result of another disease or condition.
The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 ?g/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.
Iron Chelation Drug Market contains market size and forecasts of Iron Chelation Drug in global, including the following market information:

• Global Iron Chelation Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Iron Chelation Drug Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Iron Chelation Drug companies in 2021 (%)

The global Iron Chelation Drug market was valued at 735.7 million in 2021 and is projected to reach US$ 456.1 million by 2028, at a CAGR of -6.6% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Deferasirox Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Iron Chelation Drug include Novartis, Chiesi Group, Sun Pharma, Cipla, Natco Pharma, Taro Pharm and Gland Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Iron Chelation Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Iron Chelation Drug Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Iron Chelation Drug Market Segment Percentages, by Type, 2021 (%)

• Deferasirox
• Deferoxamine
• Deferiprone

Global Iron Chelation Drug Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Iron Chelation Drug Market Segment Percentages, by Application, 2021 (%)

• Transfusional Iron Overload
• NTDT Caused Iron Overload

Global Iron Chelation Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Iron Chelation Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:

• Key companies Iron Chelation Drug revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Iron Chelation Drug revenues share in global market, 2021 (%)
• Key companies Iron Chelation Drug sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Iron Chelation Drug sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novartis
• Chiesi Group
• Sun Pharma
• Cipla
• Natco Pharma
• Taro Pharm
• Gland Pharma

To know more about market statistics, Download a FREE Sample copy